Clinical Trial Update: AZD7687 Multiple Ascending Dose Study [Phase 1]

View source ↗

Summary

AZD7687 underwent a Phase 1 multiple ascending dose study in overweight/obese individuals, and the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• AZD7687

Snippet

Sponsor: AstraZeneca | Conditions: Overweight, Obese | Phase 1 | Status: COMPLETED